NCT00100113

Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1

Study of Interactions Between GBR 12909 and Cocaine

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (planned)
• Sponsor: National Institute on Drug Abuse (NIDA) · NIH
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to assess potential interactions between intravenous (IV) cocaine and 3 doses of GBR 12909.

Detailed description

This is Phase 1, double-blind, placebo-controlled human laboratory clinical pharmacology study that will assess the potential interactions between IV cocaine and 3 escalating oral doses of GBR 12909. The primary objective is to determine safety of GBR 12909 administration and if there are significant interactions between GBR 12909 treatment concurrent with IV cocaine infusions.

Conditions

• Cocaine-Related Disorders

Interventions

Type	Name	Description
DRUG	GBR 12909

Timeline

• Start date: 2004-06-01
• Completion: 2005-06-01
• First posted: 2004-12-23
• Last updated: 2017-01-11

Locations

1 site across 1 country: United States